TABLE 1.
Study subjectb | CD4 count/μl | Plasma viral load/ml | Combination antiretroviral therapyc |
---|---|---|---|
1 | 2 | 75,000 | No |
2 | 17 | 750,000 | Yes |
3 | 39 | 309 | Yes |
4 | 51 | 23,100 | No |
5 | 66 | 75,000 | Yes |
6 | 117 | 75,000 | Yes |
7 | 123 | 330,000 | Yes |
8 | 296 | 470 | Yes |
9 | 328 | <50 | Yes |
10 | 334 | <50 | No |
11 | 339 | 14,900 | Yes |
12 | 364 | 304 | No |
13 | 385 | 153 | Yes |
14 | 393 | 403 | Yes |
15 | 396 | 862 | No |
16 | 509 | <50 | Yes |
17 | 531 | <50 | Yes |
18 | 647 | 13,400 | No |
19A | 824 | 1,900 | Yes |
19B | 887 | <50 | Yes |
Ranked by CD4 count (from low to high).
Identification numbers of long-term nonprogressors are italicized. Blood samples were drawn from subject 19 on two occasions.
Yes, subject was prescribed at least three antiretroviral agents at the time when the sample was drawn.